Please Wait
Applying Filters...
menu
    • menu
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    An Enquiry

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Istaroxime

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Panacea Forms Seismic Pharma For Clinical Heart Failure Portfolio
    Panacea Forms Seismic Pharma For Clinical Heart Failure Portfolio

    30 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/panacea-capital-leads-formation-of-seismic-pharma-to-advance-novel-clinical-stage-heart-failure-portfolio-302728098.html

    PR NEWSWIRE
    30 Mar 2026
    Share Share
    Windtree Therapeutics Enhances Istaroxime Patent Portfolio
    Windtree Therapeutics Enhances Istaroxime Patent Portfolio

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188356/0/en/Windtree-Therapeutics-Announces-More-Strengthening-of-Its-Istaroxime-and-Next-Generation-SERCA2a-activator-Patent-Estate.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    Windtree’s Istaroxime Picked for Heart Failure Presentation
    Windtree’s Istaroxime Picked for Heart Failure Presentation

    11 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/11/3130951/0/en/Windtree-Announces-Istaroxime-has-been-Chosen-for-a-Plenary-Session-Presentation-at-the-Heart-Failure-Society-of-America-2025.html

    GLOBENEWSWIRE
    11 Aug 2025
    Share Share
    Windtree's Istaroxime Phase 2 Interim Analysis Reveals Data
    Windtree's Istaroxime Phase 2 Interim Analysis Reveals Data

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127444/0/en/Windtree-Announces-Istaroxime-Phase-2-Interim-Analysis-in-SCAI-Stage-C-Cardiogenic-Shock-Patients.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Windtree Receives US Patent for Istaroxime in Acute Heart Failure
    Windtree Receives US Patent for Istaroxime in Acute Heart Failure

    02 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/02/3109196/0/en/Windtree-Announces-Issuance-of-Istaroxime-Patent-for-the-United-States-for-Acute-Heart-Failure.html

    GLOBENEWSWIRE
    02 Jul 2025
    Share Share
    Windtree's Istaroxime Phase 2 Study Hits Enrollment Target
    Windtree's Istaroxime Phase 2 Study Hits Enrollment Target

    30 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/30/3107549/0/en/Windtree-Announces-Istaroxime-Phase-2-Cardiogenic-Shock-Study-Hits-Enrollment-Target-for-Planned-Interim-Analysis.html

    GLOBENEWSWIRE
    30 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.